Pharmacogenomics of Dementia: Personalizing the treatment of cognitive and neuropsychiatric symptoms

B Vuic, T Milos, L Tudor, M Nikolac Perkovic… - Genes, 2023 - mdpi.com
Dementia is a syndrome of global and progressive deterioration of cognitive skills,
especially memory, learning, abstract thinking, and orientation, usually affecting the elderly …

How do nursing home nurses conceptualize the management of behavioral and psychological symptoms of dementia? A phenomenographic study

D Kim, YR Choi, YN Lee… - Nursing & Health …, 2024 - Wiley Online Library
The behavioral and psychological symptoms of dementia (BPSD) present complex
challenges for nursing home (NH) nurses, leading to confusion and difficulties in providing …

Associations between the Use of Metformin and Behavioral and Psychological Symptoms in Patients with Alzheimer´ s Disease, and Type 2 Diabetes Mellitus–A …

H Kullenberg, M Wibom, M Kumlin… - Current Alzheimer …, 2023 - ingentaconnect.com
Background: Metformin, the first-line anti-diabetic drug treatment in patients with type 2
diabetes mellitus (T2DM), is suggested to be anti-inflammatory, antioxidative, and improve …

[HTML][HTML] The 40-Hz White Light Emitting Diode to Alleviate Psychiatric Symptoms Induced by Streptozotocin In Vivo

E Soleimani, A Ahmadiani, M Bazrgar… - Basic and Clinical …, 2024 - pmc.ncbi.nlm.nih.gov
Introduction: A 40-Hz white light emitting diode (WLED) has emerged as an alternative
nonpharmacological and noninvasive approach to Alzheimer disease (AD). Here, we …

Comment on “The Relationship Between Antipsychotics, Cognitive Enhancers, and Major Adverse Cardiovascular/Cerebrovascular Events (MACCE) in Older Adults …

H Lenoir - Drugs & Aging, 2024 - Springer
The recent publication by DeMercy and Brenner on the relationship between antipsychotics,
cognitive enhancers (cholinesterase inhibitors or memantine), and the onset of major …

The 40 Hz White LED Alleviates Psychiatric Symptoms Induced by STZ in Vivo: Evidence from Behavioral and Molecular Studies

E Soleimani, A Ahmadiani, M Bazrgar… - Basic and Clinical …, 2024 - search.proquest.com
Introduction: The use of a 40 Hz white light emitting diode (WLED) has emerged as an
alternative non-pharmacological and non-invasive approach to Alzheimerʼs disease (AD) …

Cost-effectiveness of Dementia Medication

N Khera, RG Raj, R Kumar, M Bajaj… - Current Indian …, 2024 - benthamdirect.com
Aim This review has examined and organized the available research on dementia
medication care costs. Although the accessible database in this area is growing and is still …

Insulin-Degrading Enzyme: A link between insulin resistance and Alzheimer's disease

H Kullenberg - 2023 - diva-portal.org
Background: Prior research has demonstrated an elevated risk of Alzheimer's disease (AD)
among individuals diagnosed with type 2 diabetes mellitus (T2DM). Insulin resistance is a …

Confronto tra tre protocolli di stimolazione cognitiva nel Disturbo Neurocognitivo Maggiore di stadio lieve: effetti specifici e di generalizzazione.

M CORTESE - thesis.unipd.it
Nel mondo circa 50 milioni di persone sono affette da un tipo di Disturbo Neurocognitivo
(DNC) Maggiore e questa diffusione, in assenza di una terapia farmacologica in grado di …

[引用][C] The 40 Hz White LED Alleviates Psychiatric Symptoms Induced by STZ in Vivo: Evidence from Behavioral and Molecular Studies

A Ahmadiani, E Soleimani… - Basic and Clinical … - Basic and Clinical Neuroscience